These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18060054)

  • 21. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine.
    Valdivia CR; Ackerman MJ; Tester DJ; Wada T; McCormack J; Ye B; Makielski JC
    Cardiovasc Res; 2002 Aug; 55(2):279-89. PubMed ID: 12123767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant.
    Lin MT; Wu MH; Chang CC; Chiu SN; Thériault O; Huang H; Christé G; Ficker E; Chahine M
    Heart Rhythm; 2008 Nov; 5(11):1567-74. PubMed ID: 18848812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in cardiac sodium channels: clinical implications.
    Liu H; Clancy C; Cormier J; Kass R
    Am J Pharmacogenomics; 2003; 3(3):173-9. PubMed ID: 12814325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel.
    Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL
    Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digenic inheritance novel mutations in SCN5a and SNTA1 increase late I(Na) contributing to LQT syndrome.
    Hu RM; Tan BH; Orland KM; Valdivia CR; Peterson A; Pu J; Makielski JC
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H994-H1001. PubMed ID: 23376825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment.
    Kim HJ; Kim BG; Park JE; Ki CS; Huh J; Youm JB; Kang JS; Cho H
    Sci Rep; 2019 Sep; 9(1):12997. PubMed ID: 31506521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
    Clancy CE; Tateyama M; Kass RS
    J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis.
    Wehrens XH; Abriel H; Cabo C; Benhorin J; Kass RS
    Circulation; 2000 Aug; 102(5):584-90. PubMed ID: 10920073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
    Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
    Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
    Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
    Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits.
    Tan BH; Pundi KN; Van Norstrand DW; Valdivia CR; Tester DJ; Medeiros-Domingo A; Makielski JC; Ackerman MJ
    Heart Rhythm; 2010 Jun; 7(6):771-8. PubMed ID: 20226894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption.
    Wu G; Ai T; Kim JJ; Mohapatra B; Xi Y; Li Z; Abbasi S; Purevjav E; Samani K; Ackerman MJ; Qi M; Moss AJ; Shimizu W; Towbin JA; Cheng J; Vatta M
    Circ Arrhythm Electrophysiol; 2008 Aug; 1(3):193-201. PubMed ID: 19684871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique mixed phenotype and unexpected functional effect revealed by novel compound heterozygosity mutations involving SCN5A.
    Medeiros-Domingo A; Tan BH; Iturralde-Torres P; Tester DJ; Tusié-Luna T; Makielski JC; Ackerman MJ
    Heart Rhythm; 2009 Aug; 6(8):1170-5. PubMed ID: 19632629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
    Fredj S; Sampson KJ; Liu H; Kass RS
    Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LQT syndromes--current status of molecular mechanisms.
    Schulze-Bahr E; Wedekind H; Haverkamp W; Borggrefe M; Assmann G; Breithardt G; Funke H
    Z Kardiol; 1999 Apr; 88(4):245-54. PubMed ID: 10408028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
    Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
    Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.